FIELD: biochemistry.
SUBSTANCE: invention relates to biochemistry. Disclosed is use of antibodies or antigen-binding fragments thereof with binding specificity for ICAM-1, for use in treatment of cancer in patients who have previously been treated for cancer and either not responded to said treatment or have previously responded to said treatment and subsequently relapsed.
EFFECT: invention can be used for efficient management of recurrent forms of cancer, particularly multiple myeloma.
45 cl, 23 dwg, 2 tbl, 11 ex
